Northeast Financial Consultants Inc - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 333 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 2.08 and the average weighting 0.2%.

Quarter-by-quarter ownership
Northeast Financial Consultants Inc ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$245,000
-20.7%
2,7550.0%0.02%
-5.6%
Q1 2022$309,000
+6.6%
2,755
+46.9%
0.02%0.0%
Q4 2021$290,000
+11.1%
1,8760.0%0.02%
+5.9%
Q3 2021$261,000
+6.1%
1,8760.0%0.02%0.0%
Q2 2021$246,000
+15.0%
1,876
-2.0%
0.02%
-19.0%
Q2 2020$214,000
+7.0%
1,9150.0%0.02%
+16.7%
Q4 2019$200,000
-8.7%
1,9150.0%0.02%
-18.2%
Q2 2019$219,000
-9.1%
1,9150.0%0.02%
-18.5%
Q1 2019$241,0001,9150.03%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
KNOTT DAVID M 353,041$25,673,00016.20%
Stonepine Capital Management, LLC 160,919$11,702,00012.38%
VILLERE ST DENIS J & CO LLC 635,758$46,232,0003.94%
CARDINAL CAPITAL MANAGEMENT LLC /CT 982,049$71,415,0003.51%
Elk Creek Partners, LLC 246,251$17,907,0003.08%
Tygh Capital Management, Inc. 151,792$11,038,0002.47%
Roubaix Capital, LLC 20,034$1,457,0002.21%
Conestoga Capital Advisors, LLC 648,603$47,166,0001.38%
RICE HALL JAMES & ASSOCIATES, LLC 338,376$24,607,0001.38%
Ikarian Capital, LLC 200,000$14,544,0001.09%
View complete list of LIGAND PHARMACEUTICALS INC shareholders